Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-349,241
Closed -$14M 1999
2025
Q1
$14M Buy
349,241
+72,003
+26% +$3.03M 0.58% 23
2024
Q4
$12.7M Sell
277,238
-354,408
-56% -$15.9M 0.47% 40
2024
Q3
$29.6M Buy
631,646
+625,749
+10,611% +$28.5M 1% 6
2024
Q2
$249K Buy
5,897
+2,060
+54% +$90.3K 0.01% 800
2024
Q1
$170K Buy
+3,837
New +$175K 0.01% 994

Other funds holding QGEN

Point72 (DIFC)'s QGEN Position: Q2 2025 in Review

Point72 (DIFC) sold out of Qiagen (QGEN) in Q2 2025, closing a stake of 349,241 shares — an estimated $14M sold.

Point72 (DIFC) first reported a position in QGEN in Q1 2024 and held it in 5 quarters. The position peaked at $29.6M in Q3 2024. 317 funds tracked by Wall St. Rank hold QGEN as of Q2 2025.

  • Point72 (DIFC) reported no remaining Qiagen position as of Q2 2025 after selling out during the quarter.
  • Point72 (DIFC) sold 349,241 Qiagen shares in Q2 2025, an estimated $14M.
  • Point72 (DIFC) first reported a position in Qiagen in Q1 2024 and held it in 5 quarters.
  • Point72 (DIFC)'s Qiagen position peaked at $29.6M in Q3 2024.
  • 317 funds tracked by Wall St. Rank held Qiagen as of Q2 2025.

Based on Point72 (DIFC)'s 13F filing for Q2 2025, filed 14 Aug 2025.